Risk for HIV-1 infection associated with a common CXCL12 (SDF1) polymorphism and CXCR4 variation in an African population

Loading...
Thumbnail Image

Authors

Petersen, Desiree C.
Glashoff, Richard H.
Sherestha, Sadeep
Bergeron, Julie
Laten, Anette
Gold, Bert
Janse van Rensburg, Estrelita
Dean, Michael
Hayes, Vanessa M.

Journal Title

Journal ISSN

Volume Title

Publisher

Lippincott Williams and Wilkins

Abstract

CXC chemokine ligand 12 (CXCL12), or stromal cell–derived factor 1 (SDF1), is the only known natural ligand for the HIV-1 coreceptor, CXC chemokine receptor 4 (CXCR4). A single nucleotide polymorphism (SNP) in the CXCL12 gene (SDF1-3'A) has been associated with disease progression to AIDS in some studies, but not others. Mutations in the CXCR4 gene are generally rare and have not been implicated in HIV-1/AIDS pathogenesis. This study analyzed the SDF1-3'A SNP and performed mutation screening for polymorphic markers in the CXCR4 gene to determine the presence or absence of significant associations with susceptibility to HIV-1 infection. The study consisted of 257 HIV-1–seropositive patients and 113 HIV-1–seronegative controls representing a sub-Saharan African population belonging to the Xhosa ethnic group of South Africa. The SDF1-3'A SNP was associated with an increased risk for HIV-1 infection (P = 0.0319) whereas no significant association was observed between the occurrence of the SDF1-3'A SNP and increased or decreased plasma levels of CXCL12. Comprehensive mutation analysis of the CXCR4 gene confirmed a high degree of genetic conservation within the coding region of this ancient population.

Description

Keywords

CXC chemokine ligand 12 (CXCL12), CXC chemokine, SDF1-3'A single-nucleotide polymorphism, HIV-1 infection risk, African population

Sustainable Development Goals

Citation

Petersen, DC, Glashoff, RH, Shrestha, S, Bergeron, J, Laten, A, Gold, B, Janse van Rensburg, E, Dean, M & Hayes, VM 2005,'Risk for HIV-1 infection associated with a common CXCL12 (SDF1) polymorphism and conservation of CXCR4 in an African population', Journal of Acquired Immune Deficiency Syndrome, vol. 40, no. 5, pp. 521-526.[http://www.lww.com/product/?1525-4135]